drugset / Trial / NCT00899054

Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer

NCT00899054 ↗

Phase 1/2 Completed 23 enrolled Piramal Enterprises Limited
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to identify a dose of P276-00 that can be safely administered along with Radiation and to examine safety and efficacy of the combination in treatment of advanced head and neck cancer.

Timeline

Start
2009-08
Primary completion
2011-01
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject P276-00 Small molecule 100 mg/m2 Intravenous
Subject P276-00 Small molecule 140 mg/m2 Intravenous
Subject P276-00 Small molecule 185 mg/m2 Intravenous